Demographics of the patients
| Complete patient data | No outcome data | |
|---|---|---|
| n = 162 (108 men,54 women) | n = 22 (12 men,10 women) | |
| Mean (SD) | Mean (SD) | |
| BMI, body mass index; DLCO: diffusing capacity of lungs for carbon monoxide; FEV1: forced expiratory volume in one second; FFMI, Fat-Free Mass Index; GOLD, Global Initiative for Chronic Obstructive Lung Disease; QMVC, quadriceps maximal voluntary contraction. | ||
| We found no significant differences between the patients in whom outcome data were available and those for whom they were not. | ||
| Age when tested (years) | 63.7 (9.3) | 66.7 (9.5) |
| Height (m) | 1.7 (0.09) | 1.67 (0.09) |
| Weight (kg) | 70.2 (16.3) | 70.4 (15.7) |
| BMI (kg/m2) | 24.4 (5) | 25.2 (4.7) |
| FFMI in men (kg/m2) | 17.1 (2.3) | 17.9 (2.5) |
| FFMI in women (kg/m2) | 15.8 (2.3) | 15.7 (1.7) |
| FEV1(l) | 0.98 (0.44) | 1.02 (0.3) |
| FEV1% predicted | 35.6 (16.2) | 42.2 (9.3) |
| DLCO % predicted | 37.3 (17.6) | 41.2 (12.1) |
| GOLD stage | ||
| 0 | 0 (0%) | 0 (0%) |
| 1 | 2 (1.2%) | 0 (0%) |
| 2 | 29 (17.9%) | 3 (13.6%) |
| 3 | 56 (34.6%) | 9 (40.9%) |
| 4 | 75 (46.3%) | 10 (45.5%) |
| QMVC (kg) | 32.4 (11.5) | 35.7 (13.3) |
| QMVC as a % of BMI | 135.5 (46.7) | 142.7 (50.5) |